1,152
Views
75
CrossRef citations to date
0
Altmetric
Review

Late onset Alzheimer’s disease in older people

Pages 307-311 | Published online: 11 Oct 2010

References

  • SloanePDZimmermanSSuchindranCThe public health impact of Alzheimer’s disease, 2000–2050: Potential implication of treatment advancesAnnu Rev Public Health20022321323111910061
  • HirtzDThurmanDJGwinn-HardyKHow common are the “common” neurologic disorders?Neurology20076832633717261678
  • QuerfurthHWLaFerlaFMMechanisms of disease: Alzheimer’s diseaseN Engl J Med201036232934420107219
  • den DunnenWFBrouwerWHBijlardENo disease in the brain of a 115-year-old womanNeurobiol Aging2008291127113218534718
  • DrachmanDAAging of the brain, entropy, and Alzheimer diseaseNeurology2006671340135217060558
  • HarmanDAlzheimer’s disease pathogenesis: Role of agingAnn N Y Acad Sci2006106745446016804026
  • SchellenbergGDGenetic dissection of Alzheimer’s disease, a heterogeneous disorderProc Natl Acad Sci U S A199592855285597567974
  • HoltzmanDMRole of ApoE/Aβ interactions in the pathogenesis of Alzheimer’s disease and cerebral amyloid angiopathyJ Mol Neurosci20011714715511816788
  • PattersonCFeightnerJWGarciaADiagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer diseaseCMAJ200817854855618299540
  • BarnesDECovinskyKEWhitmerRACommentary on “Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.” Dementia risk indices: A framework for identifying individuals with a high dementia riskAlzheimers Dement2010613814120298975
  • BussiereTGiannakopoulosPBourasCProgressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predict cognitive impairment in Alzheimer’s disease: Stereologic analysis of prefrontal cortex areaJ Comp Neurol200346328130212820162
  • GarryLWNeuropathologic changes in Alzheimer’s disease: Potential target for treatmentJ Clin Psychiatry200667Suppl 337
  • CotmanCWSuJHMechanisms of neuronal death in Alzheimer’s diseaseBrain Pathol199664935068944319
  • BraakHBraakENeuropathologic staging of Alzheimer-related changesActa Neuropathol (Berl)1991822392591759558
  • ArendtTSynaptic degeneration in Alzheimer’s diseaseActa Neuropathol200911816717919390859
  • ColemanPDYaoPJSynaptic slaughter in Alzheimer’s diseaseNeurobiol Aging2003241023102714643374
  • LustbaderJWCirilliMLinCABAD directly links Abeta to mitochondrial toxicity in Alzheimer’s diseaseScience200430444845215087549
  • NewmanMMusgraveFILardelliMAlzheimer disease: Amyloidogenesis, the presenilins and animal modelsBiochimica Biophysica Acta20071772285297
  • WellerROBocheDNicollJARMicrovasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapyActa Neuropathol20091188710219234858
  • PriceJMChiXHellermannGSuttonETPhysiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide productionNeurol Res20012350651211474807
  • DeaneRZlokovicBVRole of the blood-brain barrier in the pathogenesis of Alzheimer’s diseaseCurr Alzheimer Res2007419119717430246
  • IsikATBozogluEInsulin resistance in Alzheimer’s diseaseAucoinLPrideuxTHandbook of Type 1 Diabetes Mellitus: Etiology, Diagnosis, and TreatmentHauppauge, NYNova Science2010
  • IsikATCelikTUlusoyGCurcumin ameliorates impaired insulin/IGF signaling and memory deficit in streptozotocin treated rat modelAge200931394919234767
  • JolivaltCGLeeCABeiswengerKKDefective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: Parallels with Alzheimer’s disease and correction by insulinJ Neurosci Res2008863265327418627032
  • de la MonteSMWandsJRReview of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer’s diseaseJ Alzheimers Dis20057456115750214
  • PopescuBOToescuECPopescuLMBlood-brain barrier alterations in ageing and dementiaJ Neurol Sci20092839910619264328
  • Alzheimer’s Association2010 Alzheimer’s disease facts and figuresAlzheimers Dement2010615819420298981
  • SalthouseTAMemory aging from 18 to 80Alzheimer Dis Assoc Disord20031716216714512830
  • TreitzFHHeyderKDaumIDifferential course of executive control changes during normal agingNeuropsychol Dev Cogn B Aging Neuropsychol Cogn20071437039317612814
  • IsikATApproach the elderly patient with forgetfulnessJournal of Geriatrics and Geriatric Neuropsychiatry200923338
  • WaldemarGDuboisBEmreMRecommendations for the diagnosis and management of Alzheimer’s disease and other disorders associated with dementia: EFNS guidelineEur J Neurol2007141e1e2617222085
  • JostBCGrossbergGTThe evolution of psychiatric symptoms in Alzheimer’s disease: A natural history studyJ Am Geriatr Soc199644107810818790235
  • BeierMTTreatment strategies for the behavioral symptoms of Alzheimer’s disease: Focus on early pharmacologic interventionPharmacotherapy200727339941117316151
  • National Institute on AgingUnderstanding stages and symptoms of Alzheimer’s disease2007 Available at: http://www.nia.nih.gov/alzheimers/publications/stages.htm. Accessed 2008 Feb 21.
  • MölsäPKMarttilaRJRinneUKLong-term survival and predictors of mortality in Alzheimer’s disease and multi-infarct dementiaActa Neurol Scand1995911591647793228
  • MuckeLAlzheimer diseaseNature200946189589719829367
  • DuboisBFeldmanFJacovaCResearch criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteriaLancet Neurol2007673474617616482
  • SabbaghNMDrug development for Alzheimer’s disease: Where are we now and where are we headed?Am J Geriatr Pharmacother2009716718519616185
  • IsikATCelikTUralAUTosunMDoes the mesenchymal stem cell therapy improve the streptozotocin induced neurodegeneration in rats?Alzheimers Dement20106Suppl 1569
  • SzekelyCABreitnerJCZandiPPPrevention of Alzheimer’s diseaseInt Rev Psychiatry20071969370618092245
  • TanZSBeiserASAuRPhysical activity and risk of dementia: The Framingam studyAlzheimers Dement20106Suppl 1S68